Case report: Efficacy of ponatinib in a case of chronic myeloid leukemia with a complicated clonal evolution including a myelodysplastic syndrome

@inproceedings{McCarvill2018CaseRE,
  title={Case report: Efficacy of ponatinib in a case of chronic myeloid leukemia with a complicated clonal evolution including a myelodysplastic syndrome},
  author={William McCarvill and Harold J. Olney and Xiaoduan Weng and Boli Fan and Denis Souli{\`e}res},
  year={2018}
}
Abstract Chronic myeloid leukemia (CML) is characterised by the presence of the Philadelphia chromosome (Ph), which results in the production of the constitutively active tyrosine kinase BCR-ABL1, with tyrosine kinase inhibitors (TKI) 

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
VIEW 1 EXCERPT